Search
Displaying results 751 to 760 of 763.
MyxoTech takes off
What is the concept of MyxoTech? Nature has historically been a valuable source of small molecule therapeutics. HIPS and HZI have a long tradition of using such molecules as basis for the development of innovative anti-infectives. However, our efforts have generated…
Press Contact
Press and Communication We offer you the latest information on the research topics of the Helmholtz Centre for Infection Research (HZI), get you in touch with our experts and arrange interview appointments. Press photos On our web pages we provide a…
HUMAN MICROSTAR
The director’s vision HUMAN MICROSTAR Each human being forms an individual ecosystem that is exposed to a variety of different influences throughout its life, affecting current and future health as well as susceptibility to pathogens. Exposure to microbes…
Universal Flu Vaccine Candidate Protects Against Infection in Animal Models
Researchers at Cleveland Clinic’s Lerner Research Institute and the HZI have reported that their universal flu vaccine candidate elicited a strong immune response and provided protection against severe infection and rapid clearance after viral exposure in ferrets. This…
Prof. Dr. Yannic Bartsch
Prof Dr Yannic Bartsch Head of Research Group E-Mail Yannic Bartsch is the head of the Junior Research Group and W1 Professor for "Anti-viral Antibody-omics" at TWINCORE, a joint venture of the Helmholtz Centre for Infection Research (HZI) and the Hannover…
Enter the world of infection research - Open Day at the HZI
During guided tours, HZI researchers explain, for example, how new active substances against infections can be developed from natural products or how they use epidemiological studies to understand the spread of diseases and contribute to the health of the population. In…
